J2KBIO Co., Ltd. (KOSDAQ: A420570)
Health Care · Biotechnology · KR
₩9,630.00
-6.78% today · +2.2% 1Y
J2KBIO Co., Ltd. (KOSDAQ: A420570) operates in the Biotechnology industry within the Health Care sector. The company is valued at $39.84M.
Over the last twelve months the share price has gained 2.2%, trading between 6.71K and 12.86K.
Tweenvest scores J2KBIO Co., Ltd. across four factors: quality 69/100, value 61/100, growth 66/100, dividend 55/100. Its strongest factor is quality.
A420570 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $39.84M
- Revenue (TTM)
- $28.35M
- P/E
- 9.68
- EPS
- 994.44
- Dividend yield
- 2.60%
- Beta (5Y)
- 0.28
- 52-week high
- ₩12,860.00
- 52-week low
- ₩6,710.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.85M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.08 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $442.95 | -0.20% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.96 | +0.15% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $549.00 | +0.26% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $834.94 | +0.78% |
| argenx SEENXTBR: ARGX | $63.06B | €872.20 | +0.93% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $144.03 | +3.70% |
Figures last refreshed Aug 18, 2026.